PCRX icon

Pacira BioSciences
PCRX

Overview Fund Activity

210 hedge funds and large institutions have $1.57B invested in Pacira BioSciences in 2019 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 77 increasing their positions, 63 reducing their positions, and 34 closing their positions.

Holders
210
Holders Change
+2
Holders Change %
+0.96%
% of All Funds
4.55%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
38
Increased
77
Reduced
63
Closed
34
Calls
$9.45M
Puts
$5.23M
Net Calls
+$4.22M
Net Calls Change
-$19.3M

Top Buyers

1
FCM
1
Frontier Capital Management
Massachusetts
$52.5M
2
AC
2
Armistice Capital
New York
$40.8M
3
Renaissance Technologies
3
Renaissance Technologies
New York
$40.5M
4
D.E. Shaw & Co
4
D.E. Shaw & Co
New York
$35.9M
5
Deutsche Bank
5
Deutsche Bank
Germany
$31.8M

Top Sellers

1
HM
1
HealthCor Management
New York
$26.9M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$14M
3
PC
3
Polar Capital
United Kingdom
$0
4
Macquarie Group
4
Macquarie Group
Australia
$68.7M
5
DCM
5
Daruma Capital Management
New York
$6.75M
Name Holding Trade Value Shares
Change 		Shares
Change %
Invesco
26
Invesco
Georgia
$15.1M +$922K +24,225 +6%
Public Employees Retirement Association of Colorado
27
Public Employees Retirement Association of Colorado
Colorado
$14.5M – – –
TCIM
28
TIAA CREF Investment Management
New York
$14.5M +$181K +4,763 +1%
T. Rowe Price Associates
29
T. Rowe Price Associates
Maryland
$14M -$27.3M -717,082 -66%
Dimensional Fund Advisors
30
Dimensional Fund Advisors
Texas
$13.4M +$4.24M +111,505 +46%
Canada Pension Plan Investment Board
31
Canada Pension Plan Investment Board
Ontario, Canada
$13.1M +$6.82M +179,170 +108%
TA
32
Tamarack Advisers
California
$12.2M +$12.2M +320,000 New
PCM
33
Penn Capital Management
Pennsylvania
$11M +$2.48M +65,073 +29%
Charles Schwab
34
Charles Schwab
California
$11M +$1.17M +30,783 +12%
TA
35
Teachers Advisors
New York
$10.8M +$6.01M +157,840 +126%
PHS
36
PFM Health Sciences
California
$10.7M -$9.18M -241,300 -46%
PC
37
Paulson & Co
New York
$9.52M +$9.52M +250,000 New
PCM
38
Peregrine Capital Management
Minnesota
$9.21M +$1.56M +40,889 +20%
Two Sigma Advisers
39
Two Sigma Advisers
New York
$9.13M -$1.16M -30,600 -11%
SCM
40
Spyglass Capital Management
California
$9.07M +$4.5M +118,170 +98%
Bank of America
41
Bank of America
North Carolina
$8.71M +$274K +7,205 +3%
Bank of New York Mellon
42
Bank of New York Mellon
New York
$8.32M +$318K +8,362 +4%
Federated Hermes
43
Federated Hermes
Pennsylvania
$7.91M -$2.14M -56,132 -21%
Two Sigma Investments
44
Two Sigma Investments
New York
$7.53M -$3.37M -88,503 -31%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$7.53M +$713K +18,723 +10%
PAMU
46
Pictet Asset Management (UK)
United Kingdom
$7.31M +$2.45M +64,400 +50%
Citadel Advisors
47
Citadel Advisors
Florida
$6.95M +$508K +13,341 +8%
CAM
48
Cortina Asset Management
Wisconsin
$6.93M -$1.61M -42,316 -19%
ORI
49
Oak Ridge Investments
Illinois
$6.87M -$330K -8,663 -5%
DCM
50
Daruma Capital Management
New York
$6.75M -$10.7M -282,319 -61%
1
2
3 4 5